Anticancer drug development: the grand challenges

Abstract

Despite vast investment in oncology R&D, the translation of research advances into medicines that substantially improve the treatment of many cancers remains frustratingly slow. What are the key challenges in anticancer drug development, and how might they be addressed?

DOI: 10.1038/nrd3144
0502008200920102011201220132014201520162017
Citations per Year

272 Citations

Semantic Scholar estimates that this publication has 272 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Hait2010AnticancerDD, title={Anticancer drug development: the grand challenges}, author={William N. Hait}, journal={Nature Reviews Drug Discovery}, year={2010}, volume={9}, pages={253-254} }